The checkpoint inhibitor is now approved for people with advanced non-small-cell lung cancer regardless of PD-L1 biomarker levels.

However, lung cancer incidence among HIV-positive people has fallen over the past two decades.

Lung cancer continues to be one of the most common cancers, claiming more lives yearly than breast, colon and prostate cancers combined.

Now patients with non-small cell lung cancer have another targeted therapy option.

Regular screening can detect lung cancer early, when it’s easier to treat.

The combination of target drugs Tafinlar-Mekinist is approved for nearly any type of advanced solid tumor that has the BRAF gene mutation.

Can a person’s immune system help prevent two types of non-small-cell lung cancer? Here’s how Robert Keith, MD, hopes to find out.

A new report tracks the most prominent cancers for men and women and finds substantial racial disparities in cancer treatment.

After losing his never-smoker wife to lung cancer in 2011, the former NFL linebacker tackles stigma and raises awareness.

An Army veteran, retired firefighter and farmer, Jeff Meckstroth, 65, lives in Ohio. He has Stage IV metastatic non-small-cell lung cancer.